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ABSTRACT
Background: The study aims to characterise human
corneal endothelial cell (HCEnC) cultures generated
by the peel-and-digest method based on their surface
protein/carbohydrate expression pattern.
Methods: Quantitative polymerase chain reaction
was used to compare expression of vimentin, CD90,
Cytokeratin-19, ZO-1 and Claudin 14 in cultured
HCEnC and cell line B4G12 versus stromal cells.
Fluorescence-activated cell sorting was used to assess
surface protein distribution of cultured and
uncultured HCEnC. Distribution of surface proteins/
carbohydrates was visualised by immunoﬂuorescent
and lectin staining.
Results: Human corneal endothelial cell and B4G12
showed lower expression level for vimentin, CD90,
Cytokeratin-19 compared with stromal cells; while
ZO-1 was expressed in endothelial cells, Claudin 14
was detected in B4G12 only. Fluorescence-activated
cell sorting analyses revealed CD166, CD47, CD44,
CD54, CD73, CD90, CD105, CD106, CD112, CD146
and CD325 to be present, with CD34 to be absent
from cultured HCEnC. Freshly isolated, non-
cultivated HCEnCs were CD90, CD73, CD146 and
CD325 positive. Carbohydrates were detected by
lectins LCA, PHA E, PHA L, PSA, sWGA, Con A,
RCA 120 and WGA, but cultured HCEnC showed
negative for GSL I, SBA, DBA, PNA and UEA I.
Conclusion: Cultures established by the peel-and-
digest method are probably not prone to stromal
contamination, but the cells are likely to undergo
endothelial-to mesenchymal transition as suggested
by apparent morphological changes.
Key words: glycoconjugates, human corneal endothe-
lium, immunophenotyping, lectin, surface marker.
INTRODUCTION
Establishing a method for ex vivo generation of viable
human corneal endothelial cell (HCEnC) cultures has
been a major challenge in corneal endothelial
research for the last 30 years. Interdonor variability
and data reproducibility issues have been the main
drive to devise a standard model for isolating,
cultivating and expanding HCEnCs. Commercially
available SV40 immortalised cell lines such as
HCEnC-B4G12 or HCEnC-H9C1 have also been used
in research for their expression of functional proteins
resembling primary HCEnC.1 Although other clonal
cell lines have been produced in an attempt to set
up ex vivo models for corneal endothelial diseases,
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recent ﬁndings report a better resemblance of primary
isolated cells to the in vivo ones comparedwith any cell
line.2 Corneal endothelial cells have been successfully
generated fromhuman embryonic stem cells (ESCs) as
well, the latter expressing pump function-related tran-
scripts as well as other tight junction-related proteins,
such as zonula occludens-1 (ZO-1) andNa/KATPase.3
The ESC-derived HCEnCs could be a reproducible
method for generating corneal endothelium; however,
access to ESCs has been rather limited, and it has faced
ethical and technical challenges as well. Currently
considered a limiting factor in developed countries,
HCEnCs are usually obtained from cadaveric tissue.
The isolation procedure involves Descemet’s mem-
brane peeling together with the endothelium and
digestion in collagenase, which yields cell sheets that
are further dissociated by trypsinization.4 The process
generates a population of single cells, the morphology
of which can vary from cobblestone to ﬁbroblastoid.
Presence of stromal cells cannot be excluded under
such conditions. Expression of CD166/ALCAM and
Peroxiredoxin-6 has been found to be an indicative
marker for HCEnCs in situ and could be used to assess
overall purity of the cell population.5 In addition, cell
surface markers such as glypican-4 and CD200 have
been found to be speciﬁcally expressed on HCEnCs
in comparison with corneal stroma cells (CSCs).6
Recently, a panel of markers has been suggested for
the separation of adult HCEnCs.7 Besides proteins,
each cell type has its own set of surface carbohydrates
for better identiﬁcation. Thesemolecules are known to
be involved in the process of cell adhesion, differenti-
ation, development and cancer cell metastasis.8 An
impaired glycosilation proﬁle may be associated with
disease state or progression and thus be informative
about the state of cells in culture.
One of the biggest concerns when expanding
HCEnC is contamination by stromal cells during
isolation.5 Even so, some methods use enzymatic
steps, which reportedly result in a loss of phenotype
and functionality,9 and such HCEnCs are forced to
adapt to a new environment in which they are more
likely to shift to a more ﬁbroblastoid morphology,
undergoing endothelial-mesenchymal transition. It
is assumed that cultured HCEnCs secrete
transforming growth factor 2, which induces a
rearrangement of the microtubule system causing
the cells to adopt a spindle-like cell morphology.10
Because ex vivo cultivated HCEnCs do not need to
fulﬁl a barrier function any longer, their ﬁrst, new
objective is to synthesise an extracellular matrix
closely resembling ‘home’. These post-mitotic cells
have been shown de facto of being capable to divide
and migrate ex vivo, with many groups having consid-
ered them non-functional and ﬁbroblastic, because of
their lack of expression of barrier function-related
molecules in culture.7 Different types of media and
their composition have been shown to affect HCEnC
morphology ex vivo,11 while certain compounds
including Rho kinase inhibitors have been shown
to inhibit the actin cytoskeleton-related functions,
hamper cell motility, proliferation, secretion and
other functions, thus preserving the cobblestone
morphology. There is also a growing amount of
evidence suggesting that the corneal endothelium
can recover from minor injuries in animals (although
this is signiﬁcantly different among species),12 and
progenitor-like cells from the transitional zone have
been found between the trabecular meshwork and
the corneal endothelium that could respond to such
damage.13
To date, although a number of studies have
presented markers for separating HCEnCs from other
contaminating cells,4 the presence of mesenchymal
stem cell (MSC) markers, integrins, cell adhesion
molecules combined with a surface carbohydrate/
lectin proﬁling of cultured HCEnCs has not been
performed. Our aim was to characterise primary
HCEnCs from a cell surface marker (protein and
carbohydrate ‘ﬁngerprint’) perspective, which are
isolated and cultivated ex vivo, using a popular method,
known to yield successful cultures.4 Such analysis can
help set up a more robust marker panel for improved
identiﬁcation and a more standard way of expanding
HCEnCs for future tissue engineering applications.
METHODS
Isolation method
Collection of the tissue used in this study complied
with the directive of the Helsinki Declaration and
received approval from the Regional and
Institutional Research Ethics Committee at the
University of Debrecen, Hungary (DEOEC
RKEB/IKEB 3094/2010 and 14387/2013/EKU-182/
2013). All samples were collected from cadavers
according to the EU Member States’ Directive
2004/23/EC on tissue collection practice.14 Cells
were obtained from altogether 13 donors (62%
men, 38% women, ageing 77  11 years) within
24 h of death. Whole globes were sterilised using
5% povidone iodine (Egis, Hungary) and rinsed with
phosphate buffered saline (PBS) for 5 min prior to
dissecting the corneal button. Under a surgical micro-
scope, the Descemet membrane and corneal endothe-
lium were peeled off with the help of an angled
crescent knife and forceps. The tissue was then
digested in 1 mg/mL collagenase (≥125 CDU/mg)
(Sigma-Aldrich, St. Louis, MO, USA) for 2–3 h at
37°C with gentle rocking. Post-incubation, the cells
were collected by centrifugation at 800 RPM for
5 min and treated with trypsin–EDTA
(Sigma-Aldrich, St. Louis, MO, USA) to separate
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the cells into singlets. The cells were washed and
seeded on bovine ﬁbronectin-coated (Thermo Fisher
Scientiﬁc, Waltham, MA, USA) culture plates
(Corning Costar, Sigma-Aldrich, St. Louis, MO,
USA).
Corneal stroma cells were harvested from the
remaining corneal tissue rid of the endothelium and
epithelium. The central part, approximately 6–7 mm
in diameter, was dissected into 5 × 5 mm2 pieces
using a surgical blade and put into 24-well culture
plates (Corning Costar, Sigma-Aldrich, St. Louis,
MO, USA).
Cultivation method
Commercially available corneal endothelial cell line
B4G12 (Leibniz-Institut DSMZ-Deutsche Sammlung
von Mikroorganismen und Zellkulturen GmbH,
Braunschweig, Germany) was seeded into
chondroitin-sulphate-laminin-coated 24-well culture
plates (Corning Costar, Sigma-Aldrich, St. Louis,
MO, USA) and fed with Human Endothelial SFM
(Thermo Fisher Scientiﬁc,Waltham,MA, USA), on al-
ternate days. Primary HCEnCs were cultured as
before15 seeded in attachment medium containing
5% foetal bovine serum (FBS) (Biosera, Kansas City,
MO, USA) and 1% Antibiotic/Antimycotic solution
(PAA, Pasching, Austria) in Ham’s F12/M199 (1:1)
for the ﬁrst 48 h. Subsequently, it was changed to
Maintenance medium: Ham’s F12/M199 containing
5% FBS, 1% Antibiotic/Antimycotic solution, 1%
insulin-transferrin-selenite (Sigma-Aldrich, St. Louis,
MO, USA), 10 ng/mL basic ﬁbroblast growth factor
(Biovision, Milpitas, CA, USA) and 0.02 mg/mL
ascorbic acid (Duchefa Biochemie, Haarlem, The
Netherlands). Dulbecco’s Modiﬁed Eagle’s Medium
with low concentration glucose (PAA, Pasching,
Austria) was selected as culture medium for
CSCs,16,17supplemented with 10% FBS and 1%
Antibiotic/Antimycotic solution. Cells were then
incubated under adhesive conditions in a humidiﬁed
chamber at 37°C with 5% CO2 tension. Cultivation
media was changed on alternate days. Cultures were
kept for 1–3months. No cells used for the experiments
presented hereinwere subcultured or passaged.
Immunoﬂuorescent staining
Cells were seeded into 8-well chamber slides
(Nunc™ Lab-Tek™ Chamber slides, Naperville, IL,
USA) and grown using the cultivation method
described previously. HCEnCs were ﬁxed in 4%
paraformaldehyde (Sigma Aldrich St. Louis, MO,
USA) then washed with PBS and permeabilised with
0.1% Triton X-100 (Sigma Aldrich St. Louis, MO,
USA) for 5 min. After another wash, non-speciﬁc
binding sites were blocked with 1% bovine serum
albumin (Sigma Aldrich St. Louis, MO, USA) and
3% donkey serum (Sigma Aldrich St. Louis, MO,
USA) for 1 h at room temperature. Samples were
incubated with the primary antibodies overnight at
4°C. Primary HCEnC cultures were stained for MSC
and corneal endothelial cell markers: CD73, CD166,
Collagen I and IV, Na/K ATPase, ZO-1 and prolifera-
tion marker Ki-67 (Table S2). After washing with
PBS, secondary antibodies were applied and
incubated for 1 h at room temperature. Nuclei were
visualised by 40,6-diamidino-2-phenylindole
(Sigma). Negative controls were prepared without
using the primary antibodies. Images for the cell line
were captured by a BX51 Olympus microscope
(Olympus, Waltham, MA, USA) (cell^F software);
pictures of primary HCEnC were captured using a
confocal microscope, Nikon Ti-E (Volocity imaging
software, Perkin Elmer) (Nikon, Tokyo, Japan),
while images were analysed by ImageJ.18
Reverse transcription – quantitative
polymerase chain reaction analysis
AnRLTbufferwas applied to lyse culturedB4G12 and
primary CSCs. After passing the samples through
QIAshredder columns (Qiagen, Manchester, UK) to
homogenise, RNeasy mini kit (Qiagen, Manchester,
United Kingdom) was used to isolate total RNA. Ex-
tracted nucleic acid concentrations were determined
with a NanoDrop spectrophotometer (Thermo Scien-
tiﬁc, Wilmington, DE, USA). About 1 g of RNA was
transcribed into cDNA, with Superscript III reverse
transcriptase (Life Technologies, Waltham, MA,
USA) using random hexamers as primers. About 1 L
of cDNA was used in the Taqman assays perfomed
(Applied Biosystems, Waltham, MA, USA). Glyceral-
dehyde 3-phosphate dehydrogenase (GAPDH)
(Hs99999905_m1) was used as a housekeeping gene
todeterminerelativeexpressionlevelsofgenes.CDNA
was ampliﬁed on anMx3005P polymerase chain reac-
tion (PCR) system (Stratagene, Agilent Technologies,
SantaClara,CA,USA), and resultswere analysedwith
a real-time PCRMiner algorithm.19
In case of primary HCEnCs, total RNA was
extracted using TRIzol Reagent (UD-GenoMed
Medical Genomic Technologies Ltd., Debrecen,
Hungary) according to the manufacturer’s instruc-
tions, and RNA concentration and purity was
measured using Nanodrop. Reverse transcription
was performed using the High Capacity cDNA
Archive Kit (Applied Biosystems, Abingdon, UK)
with 200 ng total RNA per 20 μl RT reaction. The
qRT-PCR was performed using the StepOnePlus
RT-PCR system (Applied Biosystems) and Taqman
Gene Expression assays following protocols from
the manufacturer for genes CD90/THY1
(Hs00174816_m1), claudin14 (Hs 00273267_s1),
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cytokeratin-19 (Hs 00761767_s1), vimentin (Hs
00185584_m1) and ZO-1 (Hs 01551861_m1). Thermo
cycling conditions were 95°C for 10 min followed by
40 cycles of 95°C for 15 s and 60°C for 1 min. The data
were analysed by the 2ΔΔCt method as the fold
change in gene expression relative to HCEnC, which
was arbitrarily chosen as the calibrator and equals
one, and GAPDH was used as housekeeping gene.
All samples were run in triplicates.
GAPDH was used to determine relative gene
expression levels, and then fold changes were calcu-
lated in B4G12 and primary HCEnCs versus primary
CSCs.
Flow cytometric surface marker analysis
For immunophenotyping, primary HCEnC and CSCs
were cultured in a single well of 24-well plate
(1.9 cm2) until they reached conﬂuency (average time
to conﬂuency: 27.5  3.5 days). Four donors were
submitted to three-colour ﬂuorescence-activated cell
sorting (FACS) analysis. Fluorescein-isothiocyanate
(FITC), phycoerithrin and allophycocyanin-
conjugated primary antibodies CD146, CD47,
CD112 (R&D Systems, MN, USA), CD90/Thy-1,
CD34, CD54, CD73, CD105, CD106, CD44, CD325
and CD166 (Biolegend, San Diego, CA, USA) were
used. Cultured cells were harvested by trypsinization
and stained with the antibodies for 30 min at 4°C,
then ﬁxed in 1% paraformaldehyde. For comparison,
the same procedure was used to stain freshly isolated
HCEnCs at time point zero, referred to as uncultured
HCEnCs, to check expression of CD73, CD90, CD44,
CD146, CD166 and CD325.
Samples were analysed on a FACS Calibur
cytometer (BD, Biosciences, Immunocytometry
Systems), and data were analysed by Flowing
Software 2.5 (Perttu Terho, Turku Centre for
Biotechnology, University of Turku, Finland). More
information about the antibodies used is provided
in (Table S3). Hierarchical clustering was
performed using the R software (version 3.3.0., R
Foundation for Statistical Computing) as described
previously.17
Surface carbohydrate staining
Human corneal endothelial cells were seeded into
8-well chamber slides and incubated with
FITC-conjugated lectins (Vector Labs, Burlingame,
CA, USA) in Lectin dilution buffer for 30 min at
4°C. Lectins against galactose and N-
acteylgalactosamines, such as Griffonia (bandeiraea)
simplicifolia lectin I (GSL I), Dolichos biﬂorus
agglutinin, Peanut agglutinin, Ricinus communis
agglutinin I (RCA 120), Soybean agglutinin (SBA),
Phaseolus vulgaris Erythroagglutinin and P. vulgaris
Leucoagglutinin (the latter two both against galac-
tose) were used. Mannose and glucose were labelled
by Concanavalin A (CON A), Lens culinaris agglutinin
and Pisum sativum agglutinin (PSA). Ulex europaeus
(UEA I) stained fucose and arabinose, while Wheat
germ agglutinin (WGA) and its succinylated form
(sWGA) binds sialic acid. Finally, Hoechst 33342
counterstaining was carried out. Surface glycoprotein
distribution was visualised, and pictures were
captured by an EVOS® FL microscope (Thermo
Fisher Scientiﬁc, Waltham, MA, USA).
Cell viability
Cellular viability was tested by trypan blue exclusion
test (Sigma-Aldrich, St. Louis, MO, USA) and
Annexin-ﬂuorescein isothiocyanate (FITC/propidium




Mann–Whitney U-test was used to reveal signiﬁcant
differences. P value of less than 0.05 was considered
signiﬁcant.
RESULTS
RT-qPCR analysis of B4G12 and primary
HCEnC in comparison to corneal stroma
cells
The relative expression of the genes previously
described in the cornea was analysed by RT-qPCR
in B4G12 cells and compared with that of primary
CSCs (GAPDH being used as a housekeeping refer-
ence gene) (Fig. 1a). A 15-fold lower expression of
vimentin was found in the cell line, compared with
CSCs. CD90/Thy-1 expression was expectedly more
prominent in CSCs with an almost 13-fold increase
in the latter, while the relative expression of
cytokeratin-19 was threefold lower in the endothelial
cell line. Levels of ZO-1 showed a 2.2-fold increased
expression in the cell line, while the tight junction
marker claudin 14 was expressed 10 times more in
the endothelial cells. Claudin 10b was not expressed
on either of the cells analysed by RT-qPCR (data
not shown). Having a similar expression pattern like
the B4G12 cell line, the primary HCEnCs showed a
3.1-fold decrease in vimentin expression and a 3.2-fold
decrease in CD90/Thy-1 compared with CSCs. The
expression of cytokeratin-19 in primary HCEnCs was
seven times lower than that of CSCs, while 4.25
times more ZO-1was expressed in HCEnCs compared
to CSCs.
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Surface protein expression pattern of
primary and uncultured HCEnC
Primary HCEnC showed moderate positivity for
CD73 (Fig. 2a), the signal from the stained protein
being expressed diffusely within the cytoplasm.
CD166 showed strong staining in the processes of
the cell membranes as they assumed a stretching
and forward-reaching morphology against each other
(Fig. 2b). Na/K-ATPase showed positivity around the
edges of HCEnCs (Fig. 2c). Staining for ZO-1 could
not be detected in the intercellular space (Fig. 2d),
but a dim signal was detected in the cytoplasm of
the cells. Extracellular matrix components Collagen
I and Collagen IV localised mainly within the cell
cytoplasm (Fig. 2e,f). Sporadic expression of nuclear
Ki-67 could be observed in the primary HCEnC
cultures (Fig. 2g,h).
For phenotypic characterization of the cultured pri-
mary HCEnCs and uncultured HCEnCs (Table S1),
Figure 2. Immunoﬂuorescent staining of primary human corneal endothelial cells. (a) CD73, (b) CD166, (c) Na/K ATPase, (d) ZO-1, (e)
Collagen I and (f) IV and (g–h) Ki-67 staining of the cells was performed using ﬂuorescein-isothiocyanate-conjugated antibodies. Nuclei
were stained by 40,6-diamidino-2-phenylindole (white bars represent 50 μm).
Figure 1. Reverse transcription – quantitative polymerase chain reaction analysis characterization of B4G12 (a) and primary human
corneal endothelial cell (b) compared with corneal stroma cells (CSCs). Relative gene expression levels were calculated with the help
of GAPDH as a reference gene, and individual gene values were normalised to that of primary CSCs. Genes with relative expression levels
SD are shown (n = 3).
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molecules representing haematopoietic and
mesenchymal cell lineages, as well as integrins and
proteins involved in cellular adhesion, were used.
CD73 expression was found to be in 89.32  1.35%
of primary cultured HCEnCs compared with
16.34  23.74% of the uncultured cells (P ≤ 0.001).
CD90/Thy-1was low or absent (7.16 4.46%) in cul-
tured cells and also showed low expression in
uncultured HCEnC (8.56  13.26%, P = 0.768).
Endoglin/CD105 protein was expressed by
49.52 17.26%of primary HCEnCs. CD47was found
highly expressed (89.12  1.92%), while CD34 –
marker of haematopoietic cells – was not expressed
(0.13  0.13%) by the cultured HCEnCs. Cell-to-cell
and cell-matrix adhesion proteins, such as CD44
(HCAM), was found on the majority of the cells with
high interdonor variability (68.39  13.13%) on pri-
mary HCEnCs, while a signiﬁcantly lower expres-
sion, 6.68  2.44% (P = 0.041), was observed in
uncultured, freshly isolated cells. Expression of
CD54 (ICAM-1) showed elevated levels
(54.33  8.03%); CD106 (VCAM-1) was found to be
donor-dependent with high interdonor variability
found on primary HCEnCs (38.08  15.23%).
CD146 (MCAM) expression showed similar positiv-
ity in primary HCEnC (43.02  15.53%) compared
with uncultured, freshly isolated cells (1.1  3.15%)
(P = 0.404). CD112 (Nectin-2) was expressed by
77.73  2.17% of the cultured HCEnCs, detected as
two population staining differently. CD166
(ALCAM) was present on the majority of the cells
(78.93  1.69%); however, signiﬁcantly lower ex-
pression of the latter was observed in uncultured cells
(20.20  11.47%) (P = 0.001). N-cadherin (CD325)
was found on 76.39  5.68% of the primary HCEnC,
showing two positive populations. It was also present
on a majority (69.61  7.08%) of uncultured cells
(P = 0.678). Hierarchical clustering of the surface
protein expression revealed a clear-cut difference
between HCEnCs compared with CSCs. Although
interdonor variability was observed in HCEnC, no re-
lation to CSCs was found, as they formed different
clusters (Fig. 3) (Table S1).
Surface lectin-carbohydrate pattern of
primary HCEnC
Fluorescein-isothiocyanate-conjugated lectins were
used to characterise the surface carbohydrate expres-
sion of primary endothelial cells (Fig. 4). Primary
HCEnC showed positive staining for RCA lectin,
recognised by terminal galactose molecules.
Similarly, P. vulgaris leucoagglutinin was detectable,
recognizing complex galactose structures. Both
succinylated and non-succinylated forms of Wheat
germ agglutinin (sWGA and WGA), recognizing
dimer and trimer N-acetylgalactosamines, were
Figure 3. Heatmap showing surface proteins
expressed by human corneal endothelial cell
(HCEnC) compared with corneal stroma cells
(CSCs). Two distinct clusters by the two cell types
are seen, exhibiting the different phenotypes of
the cells analysed (four donors of HCEnC and
three donors of CSCs are being shown). Values
0–100 represent the percentage of positive cells
for given cell surface proteins analysed by
ﬂuorescence-activated cell sorting. The P-values
represent the statistical difference between the
data obtained from HCEnCs, versus CSCs.
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detectable on the cells. Staining for L. culinaris
agglutinin, P. vulgaris erythroagglutinin, PSA and
CON A revealed that the cells expressed mannose
and D-glucose monomers and polymers.
N-acetylgalactosamine monomers were not detect-
able by lectins D. biﬂorus agglutinin, SBA and
Griffonia (bandeiraea) simplicifolia lectin I (GSL I).
UEA I, a lectin staining L-fucose and a marker for
epithelial/endothelial cells, was not detected. T-anti-
gen-binding Peanut agglutinin was not found on
primary HCEnCs.
Viability of HCEnC
The cellular viability/death assay showed that
81.84  11.44% of the primary HCEnCs were viable,
with presence of a moderate amount of necrotic cells
(26.55  15.79%) stained by propidium iodide.
Apoptotic cells (4.27  5.94%) stained by
FITC-conjugated annexin V and double-positive/
secondary necrotic or late apoptotic- (5.5  4.23%)
cells (Fig. 5) were detected, too. Representative
sample is shown in Figure S1. Trypan blue test
Figure 4. Surface carbohydrate staining of cultured human corneal endothelial cells (HCEnCs). Fluorescein-isothiocyanate-conjugated
lectin staining was performed on primary HCEnCs. Nuclei were stained by Hoechst 33342 (white bar represents 100 μm).
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validated the results, showing an overall
80.01  11.92% viability of the cultivated HCEnCs.
DISCUSSION
Isolation and cultivation of primary HCEnCs has
undergone many changes and improvements over
the last few decades. A previously described method
that is known to generate successful cultureswas used
here.21 Although many studies have claimed to have
found the optimal technique for isolation and cultivat-
ing HCEnCs,4 to date, no standard method is in place
for ex vivo cultivation of HCEnCs, with few protocols
describing how to cultivate such cells over short
periods of time. One study applying explanted tissue
from the transitional zone between the trabecular
meshwork and the corneal endothelium containing a
putative stem cell population for both membranes
has successfully achieved conﬂuent cornea endothe-
lial monolayers in a series of seven seedings over
6 months.22 It has also been reported that media con-
ditioned by bone marrow-derivedMSCs can enhance
proliferation of HCEnC and promote appearance of
function-related junction.23 A recent technique using
a dual-media approach for cultivating HCEnCs
reportedly produced a consistent method for
expanding the cells.15 The research, facing many
challenges, ultimately aims to produce a standard
method for isolation and expansion of HCEnCs for
clinical application. To date, the only preclinical trial
of transplanting cornea endothelial cell sheets using
type I collagen and performed on monkeys proved to
be unsatisfactory, and instead, single donor corneal
endothelial cells have been used to treat 243 patients
by a minimally invasive anterior chamber injection
technique.24 We hereby present characterization of
HCEnC isolated by an enzymatic method.4
While the endothelial cell line showed a fast
expansion rate, the isolated primary HCEnCs
displayed much slower proliferation rate, which took
up to 3–4 weeks of cultivation before reaching mono-
layer conﬂuence. Indirectly, such a slow rate of
expansion is reportive of the purity of the cultures,
because ﬁbroblasts are known to quickly overtake
or outgrow other cell types in vitro.25
We have previously shown a clearly differential
gene expression of limbal epithelial stem cells
compared with corneal stroma-derived
mesenchymal-like stem cells.17 In the present study,
the gene expression analysis by RT-qPCR revealed
that the cell line and the primary HCEnCs had similar
expression patterns, which clearly differed from that
of CSCs. Because contamination of HCEnCs by CSCs
is a main concern when isolating HCEnCs, the higher
expression of cell-to-cell adhesion and cell junction
genes in HCEnCs compared with CSCs further
supports the fact that our isolated HCEnCs are pure
or free from stromal cells. The intermediate ﬁlament
vimentin was expressed much higher in the CSCs as
opposed to the cell line, possibly demonstrating the
absence of endothelial-to-mesenchymal transition in
the B4G12 cells. However, presence of this protein
has been demonstrated in histological sections of
corneal endothelium in situ and in cultured HCEnCs
as well.26,27
The expression levels of tight junction genes ZO-1
and claudin 14 were also conﬁrmed in the cell line
and the primary HCEnCs; interestingly, claudin 10
was not detectable by qPCR in the latter cells, which
differed from the data obtained by immunoﬂuores-
cent staining of the protein, and also, not in line with
the ﬁndings of others.28 Other groups have reported
detecting claudin expression in B4G12 cells, which
differed from that of primary human endothelium.
They also found interindividual variations.28 The
immortalised, transformed nature of the cell line as
well as the ex vivo cultivation of HCEnCs may have
contributed to such differences. According to another
transcriptome analysis of the cell line versus primary
and ex vivo cultured corneal endothelial cells, B4G12
represents a distinct type of cell, thus not being an
optimal model for corneal endothelial studies.2
Future clinically oriented experiments should
therefore focus on using primary HCEnCs, possibly
obtained from cadavers or other sources such as
embryonic or induced pluripotent stem cells.
Figure 5. Cell viability in primary human corneal endothelial
cells. Cell cultures were stained with propidium iodide (PI) and
ﬂuorescein-isothiocyanate (FITC)-conjugated annexin V to reveal
necrotic, apoptotic or double-positive/secondary necrotic or late
apoptotic cells, respectively. Viability was measured by
ﬂuorescence-activated cell sorting analysis and data represent
three independent measurements on two donors. Data shown
are mean  SD of all measurements performed after 30 days
of cultivation. The results of the trypan blue exclusion test are
also mean  SD (n = 4).
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Characterization of the surface marker proﬁle of
corneal endothelial cells is important to determine
the purity as well as the source of these cells. It has
been claimed that high expression levels of the
markers CD98, CD166 and CD340 are characteristic
of a functional corneal endothelial phenotype, while
cells bearing CD9, CD49e, CD44 and CD73 are
ﬁbroblastic, non-functional endothelial cells, when
assayed by FACS.7 Our FACS analysis revealed that
majority of the cultured cells express CD73 and
CD44, while CD90 was absent or present in low
levels (<10%). Interestingly, the freshly isolated,
non-cultivated HCEnCs also expressed CD73 and
similarly low CD90 expression compared with the
cultured HCEnCs.
Up-regulation of the hyaluronate receptor CD44
has been described following epithelial injury in
mice29 and has been detected in normal human
colorectal cells in the proliferative regions or
crypts.30,31 CD44 has also been detected at the basal
layers of corneal epithelium, in corneal keratocytes
and in cornea stromal cells,17 and absent in the
endothelium of normal human corneas. Nonetheless,
CD44 has also been detected in endothelial cells from
the remaining parts of Fuchs dystrophy, bullous
keratopathy and late stages of graft rejection, indicat-
ing an association with loss of integrity of the
endothelial layer, while it has not been detected in
conditions such as keratoconus, Meesmann and
lattice dystrophy, where the endothelium is usually
unaffected. In the former conditions and in culture,
the cells need to expand and/or migrate in order to
cover the surface and to maintain a uniform endothe-
lial barrier, thus losing their original functions while
adapting to the new circumstances. An association
between CD44, injury and compensatory response
has been previously described by others.32 More than
half of our cultured primary HCEnCs expressed
CD44, possibly representing a population of cells
possessing a migratory, proliferative and regenera-
tive capacity. In comparison with freshly isolated,
non-cultivated HCEnCs, the expression of CD44 ap-
pears to be higher in the ex vivo expanded cells. CSCs,
on the other hand, are known to express CD73, CD90
and CD105.17 Low expression of CD90 in our
cultures demonstrates a cell population free or very
low on CD90 expressing cells – possibly CSCs.
CD90 expression of HCEnC appeared not to be ele-
vated or changed signiﬁcantly after isolation as well.
Because there is no ofﬁcial consensus on a deﬁni-
tive panel of surface molecules to identify HCEnCs,
we propose supplementing the presently known
ﬁngerprint of surface marker proteins on HCEnCs,
with a panel of positive surface carbohydrates for bet-
ter identiﬁcation and characterization of these cells.
Studies with corneal epithelial cells have reported
that the expression levels and distribution of
glycoproteins on the cell surface play a crucial role
in the regeneration the layer,33,34 and a ﬁngerprint
of carbohydrate molecules present on the cornea
limbal epithelial stem cells has also been described.20
Interestingly, the lectin staining of surface carbohy-
drate molecules on HCEnC showed similarities with
CSCs,17 probably because of their proximity or
sharing of the location in the cornea in vivo.
The levels of glycoconjugates can be altered in
different diseases affecting the cornea.35–37 Pax-6 mu-
tant mice demonstrated a disturbed glycoconjugate
function. The authors speculated that there is either
an adhesion molecule or growth factor receptor
conjugated to -N-acetylglucosamine1–4 glucose and
D-mannose and/or -D-glucose, which blocked by
WGA, and Con A leads to an elongated, insufﬁcient
response to injury in epithelial cells, in vitro.34 Several
studies have described the lectin binding pattern of
animal- and human-cornea-derived in situ endothe-
lial cells specimen; in the uninjured rat cornea, cells
could bind to lectin WGA, Con A, RCA, while not
to GSL I, SBA and UEA I36,38; GSL I B4 was found
to be a speciﬁc marker of bovine corneal endothe-
lium, while its expression in humans was restricted
to individuals with B blood type35,39; Con A,
RCA-120, GSL I, WGA and PHA were found to be
present in the basal corneal epithelial cell layers,
while the Descemet’s membrane stained for Con A,
PHA and PSA in frozen corneal sections.40 It is
known that during wound repair, corneal endothelial
cells respond to injury by exiting from the G0 phase
and up-regulation of DNA synthesis around affected
regions 24 to 66 h following injury, when mitosis
and migration happen simultaneously.41–43 More
recent reports have described a G1 arrest of the cornea
endothelial cells in vivo, while maintaining prolifera-
tive capacity.44 In intact corneal endothelium, SBA
was found to be negative, but reportedly, injured
endothelium showed SBA binding adjacent to
wounded areas after 24 h. Expression of the SBA-
bound glycoconjugate was completely abolished
after 72 h.36 A role of SBA in the re-organization of
actin skeleton in wound-repair was also suggested.45
The same group hypothesised that appearance of
SBA-bound protein might act to re-establish cell-to-
cell interaction, as it was expressed in cells under
stress, such as explantation (organ culture) or
disease, in order to conserve the integrity of the
endothelial cell layer.46 SBA was also found up-
regulated in endothelial cells of keratoconic corneas.
This suggests a relationship of surface carbohy-
drates in the structural integrity of the cornea.47 In
our study, primary HCEnCs did not exhibit any
SBA binding, which might be explained by a
restored integrity of the endothelial monolayer,
even though the cells retained a ﬁbroblastoid
morphology.
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In conclusion, our data show that a popular
method widely used for the expansion of HCEnC
produces cells that express markers associated to the
corneal endothelial phenotype. Distribution of the
proteins and carbohydrates shows a population of
cells adapting to a new environment, while
attempting to restore integrity of the original tissue.
Even so, these slowly proliferating cells slowly
undergo changes that will compromise their original
functions. Perhaps, reverting the cells back without
the use of cell-altering substances, or isolating them
in a manner so that they do not change drastically,
will enable future basic and applied research by
isolating and propagating the HCEnC for clinical
purposes. Clinical trials with HCEnCs are much
needed to reach safety and efﬁcacy of the cell therapy
awaited in the near future.
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SUPPORTING INFORMATION
Additional Supporting Informationmaybe found in the
online version of this article at the publisher's web-site:
Figure S1 Representative results from the cell
viability/death analysis by FACS.
Figure S2 Histograms showing surface marker analysis
of cultured (A) and uncultured (B) HCEnCs.
Table S1 Surface marker proﬁling of primary HCEnCs,
CSCs andunculturedHCEnCs (n=4, n = 3, n = 3, respec-
tively) by FACS analyses.
Table S2Details of the antibodies used for immunoﬂuo-
rescent staining.
Table S3 List of antibodies used for the FACS analysis.
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